Clinical Trial Update: Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies

View source ↗

Summary

A completed clinical trial/update examining leukocyte gene expression as biomarkers to guide development of novel therapies for cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: National Jewish Health | Conditions: Cystic Fibrosis, Pulmonary Exacerbation | Status: COMPLETED